Published in Int J Urol on November 01, 2005
Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature. Rare Tumors (2014) 1.48
Spontaneous tumour lysis syndrome. CMAJ (2012) 1.26
An unusual presentation of tumor lysis syndrome in a patient with advanced gastric adenocarcinoma: case report and literature review. Case Rep Med (2012) 1.07
Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer. Mol Clin Oncol (2017) 0.75
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res (2008) 14.37
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res (2007) 5.97
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol (2007) 5.23
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res (2011) 4.65
New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached". Indian J Med Res (2012) 2.83
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol (2013) 2.76
Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab (2006) 2.57
Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res (2009) 2.54
Circumcision and the risk of prostate cancer. Cancer (2012) 2.48
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
Castration-resistant prostate cancer: AUA Guideline. J Urol (2013) 2.36
Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res (2011) 2.34
Prostate cancer in men using testosterone supplementation. J Urol (2005) 2.12
The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer (2008) 1.94
Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PLoS One (2012) 1.89
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol (2010) 1.86
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate (2009) 1.83
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence. Clin Cancer Res (2009) 1.69
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res (2008) 1.68
Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer (2006) 1.67
What are the reasons for poor uptake of HIV testing among patients with TB in an Eastern India District? PLoS One (2013) 1.65
How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India? PLoS One (2011) 1.64
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients. J Urol (2012) 1.60
Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst (2011) 1.58
Male pattern baldness and prostate cancer risk in a population-based case-control study. Cancer Epidemiol (2010) 1.57
Effect of collecting duct histology on renal cell cancer outcome. J Urol (2009) 1.54
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev (2011) 1.51
Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer (2007) 1.47
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. Clin Cancer Res (2006) 1.47
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository. Urology (2009) 1.46
Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol (2007) 1.42
Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol (2010) 1.36
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology (2008) 1.32
Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control (2007) 1.30
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res (2012) 1.25
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS One (2011) 1.24
Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol (2008) 1.23
Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites. Am J Physiol Endocrinol Metab (2005) 1.21
Vitamin D pathway gene variants and prostate cancer prognosis. Prostate (2010) 1.20
MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst (2009) 1.20
Targeted androgen pathway suppression in localized prostate cancer: a pilot study. J Clin Oncol (2013) 1.14
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.12
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2010) 1.11
Testicular cancer. J Natl Compr Canc Netw (2012) 1.11
Primary scrotal cancer: disease characteristics and increasing incidence. Urology (2008) 1.09
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect. Clin Cancer Res (2010) 1.09
Do statins affect androgen levels in men? Results from the Boston area community health survey. Cancer Epidemiol Biomarkers Prev (2007) 1.08
The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol (2011) 1.08
Kidney cancer. J Natl Compr Canc Netw (2011) 1.06
Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial. J Clin Endocrinol Metab (2010) 1.04
Contemporary grading for prostate cancer: implications for patient care. Eur Urol (2012) 1.03
Evidence that the human gene for prostate short-chain dehydrogenase/reductase (PSDR1) encodes a novel retinal reductase (RalR1). J Biol Chem (2002) 1.03
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer. Clin Cancer Res (2007) 1.01
What happens after an elevated PSA test: the experience of 13,591 veterans. J Gen Intern Med (2010) 0.99
Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. Prostate (2006) 0.99
Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000. Urology (2006) 0.98
Kidney cancer, version 2.2014. J Natl Compr Canc Netw (2014) 0.98
The basic biochemistry and molecular events of hormone therapy. Curr Urol Rep (2007) 0.96
The effect of demographic and clinical factors on the relationship between BMI and PSA levels. Prostate (2011) 0.95
CYP17 polymorphisms and prostate cancer outcomes. Prostate (2010) 0.95
Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial. J Natl Cancer Inst (2013) 0.95
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation. J Clin Endocrinol Metab (2013) 0.93
Hospital-level variation in the quality of urologic cancer surgery. Cancer (2011) 0.92
Intermittent androgen deprivation: clinical experience and practical applications. Urol Clin North Am (2006) 0.91
Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. Urol Oncol (2007) 0.90
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol (2013) 0.90
Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression. Cancer Res (2009) 0.90
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate (2009) 0.89
Role of post-chemotherapy surgery in germ cell tumors. Urol Clin North Am (2007) 0.89
Association of hepsin gene variants with prostate cancer risk and prognosis. Prostate (2010) 0.88
Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw (2015) 0.86
New and novel markers for prostate cancer detection. Curr Urol Rep (2009) 0.86
Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue. Prostate (2009) 0.85
The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results. Telemed J E Health (2002) 0.85
AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. Prostate (2010) 0.84
Advanced clinical states in prostate cancer. Urol Clin North Am (2012) 0.84
Statins and the risk of cancer. JAMA (2006) 0.84
Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Cancer Causes Control (2007) 0.83
Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression. Endocrinology (2014) 0.82
Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer. Transl Oncol (2009) 0.82
Active surveillance for prostate cancer: the role of the pathologist. Pathology (2015) 0.82
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate (2010) 0.82
Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Clin Cancer Res (2004) 0.81
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch (2014) 0.81
Genetics: Prostate cancer risk stratification by genotype and PSA. Nat Rev Urol (2009) 0.80
Practical guide to the use of abiraterone in castration resistant prostate cancer. Can J Urol (2014) 0.80
Impact of male hormonal contraception on prostate androgens and androgen action in healthy men: a randomized, controlled trial. J Clin Endocrinol Metab (2012) 0.80
A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial. Prostate (2013) 0.79
A dietary intervention to elicit rapid and complex dietary changes for studies investigating the effects of diet on tissues collected during invasive surgical procedures. J Am Diet Assoc (2009) 0.79
Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India? PLoS One (2011) 0.79
A preliminary exploration of the feasibility of offering men information about potential prostate cancer treatment options before they know their biopsy results. BMC Med Inform Decis Mak (2013) 0.78
Intraprostatic steroidogenic enzymes - letter. Cancer Res (2010) 0.78
Editorial comment on "Treatment of nonretroperitoneal residual germ cell tumor masses". Urol Oncol (2005) 0.78